9788419663085_DeVita. Cancer 12ed.

328

Práctica de la oncología / Cabeza y cuello

34. Byers RM, Weber RS, Andrews T, et al. Frequency and therapeutic implica tions of “skip metastases” in the neck from squamous carcinoma of the oral tongue. Head Neck 1997;19(1):14–19. 35. Roshdy S, Elbadrawy M, Khater A, et al. Compartmental tongue resection with submental island flap reconstruction for large carcinoma of the oral tongue. Oral Maxillofac Surg 2017;21(3):289–294. 36. Roshdy S, Elbadrawy M, Khater A, et al. Erratum to: Compartmental tongue resection with submental island flap reconstruction for large carcinoma of the oral tongue. Oral Maxillofac Surg 2017;21(3):373. 37. Chang EI, Yu P, Skoracki RJ, et al. Comprehensive analysis of functional out comes and survival after microvascular reconstruction of glossectomy defects. Ann Surg Oncol 2015;22(9):3061–3069. 38. Chepeha DB, Teknos TN, Shargorodsky J, et al. Rectangle tongue template for reconstruction of the hemiglossectomy defect. Arch Otolaryngol Head Neck Surg 2008;134(9):993–998. 39. Dziegielewski PT, Ho ML, Rieger J, et al. Total glossectomy with laryngeal preservation and free flap reconstruction: objective functional outcomes and systematic review of the literature. Laryngoscope 2013;123(1):140– 145. 40. Zhang H, Dziegielewski PT, Biron VL, et al. Survival outcomes of patients with advanced oral cavity squamous cell carcinoma treated with multimodal therapy: a multi-institutional analysis. J Otolaryngol Head Neck Surg 2013; 42(1):30. 41. Rihani J, Lee MR, Lee T, et al. Flap selection and functional outcomes in total glossectomy with laryngeal preservation. Otolaryngol Head Neck Surg 2013; 149(4):547–553. 42. Mendenhall WM, Van Cise WS, Bova FJ, et al. Analysis of time-dose factors in squamous cell carcinoma of the oral tongue and floor of mouth treated with radiation therapy alone. Int J Radiat Oncol Biol Phys 1981;7(8):1005–1011. 43. Mendenhall WM, Parsons JT, Stringer SP, et al. T2 oral tongue carcinoma treated with radiotherapy: analysis of local control and complications. Radio ther Oncol 1989;16(4):275–281. 44. Wendt CD, Peters LJ, Delclos L, et al. Primary radiotherapy in the treat ment of stage I and II oral tongue cancers: importance of the proportion of therapy delivered with interstitial therapy. Int J Radiat Oncol Biol Phys 1990;18(6):1287–1292. 45. Dzioba A, Aalto D, Papadopoulos-Nydam G, et al. Functional and quality of life outcomes after partial glossectomy: a multi-institutional longitudinal study of the head and neck research network. J Otolaryngol Head Neck Surg 2017; 46(1):56. 46. Fein DA, Mendenhall WM, Parsons JT, et al. Carcinoma of the oral tongue: a comparison of results and complications of treatment with radiotherapy and/or surgery. Head Neck 1994;16(4):358–65. 47. Pernot M, Malissard L, Hoffstetter S, et al. The study of tumoral, radiobiolog ical, and general health factors that influence results and complications in a series of 448 oral tongue carcinomas treated exclusively by irradiation. Int J Radiat Oncol Biol Phys 1994;29(4):673–679. 48. Chang DT, Sandow PR, Morris CG, et al. Do pre-irradiation dental extractions reduce the risk of osteoradionecrosis of the mandible? Head Neck 2007;29(6):528–536. 49. Nair MK, Sankaranarayanan R, Padmanabhan TK. Evaluation of the role of radiotherapy in the management of carcinoma of the buccal mucosa. Cancer 1988;61(7):1326–1331. 50. Ota Y, Aoki T, Karakida K, et al. Determination of deep surgical margin based on anatomical architecture for local control of squamous cell carcinoma of the buccal mucosa. Oral Oncol 2009;45(7):605–609. 51. Cigna E, Rizzo MI, Greco A, et al. Retromolar trigone reconstructive sur gery: prospective comparative analysis between free flaps. Ann Surg Oncol 2015;22(1):272–278. 52. Lin CH, Chiu YH, Perng CK, et al. Experience with the use of free fascio cutaneous flap in through-and-through cheek-buccal defect reconstruction: surgical outcome and quality of life analysis. Ann Plast Surg 2016;76(Suppl 1): S74–S79. 53. Diaz EM Jr, Holsinger FC, Zuniga ER, et al. Squamous cell carcinoma of the buccal mucosa: one institution’s experience with 119 previously untreated patients. Head Neck 2003;25(4):267–273. 54. Mendenhall WM, Morris CG, Amdur RJ, et al. Radiotherapy alone or com bined with surgery for adenoid cystic carcinoma of the head and neck. Head Neck 2004;26(2):154–162. 55. Mendenhall WM, Morris CG, Amdur RJ, et al. Retromolar trigone squamous cell carcinoma treated with radiotherapy alone or combined with surgery. Can cer 2005;103(11):2320–2325. 56. Mendenhall WM, Werning JW, Fernandes R, et al. Ameloblastoma. Am J Clin Oncol 2007;30(6):645–648. 57. Cianchetti M, Sandow PS, Scarborough LD, et al. Radiation therapy for minor salivary gland carcinoma. Laryngoscope 2009;119(7):1334–1338. 58. Sehdev MK, Huvos AG, Strong EW, et al. Proceedings: Ameloblastoma of maxilla and mandible. Cancer 1974;33(2):324–333. 59. Hitchcock KE, Amdur RJ, Morris CG, et al. Retromolar trigone squamous cell carcinoma treated with radiotherapy alone or combined with surgery: a 10-year update. Am J Otolaryngol 2015;36(2):140–145. 60. Barr ML, Haveles CS, Rezzadeh KS, et al. Virtual surgical planning for mandibular reconstruction with the fibula free flap: a systematic review and meta-analysis. Ann Plast Surg 2020;84(1):117–122.

61. Seikaly H, Idris S, Chuka R, et al. The Alberta reconstructive technique: an occlusion-driven and digitally based jaw reconstruction. Laryngoscope 2019; 129(Suppl 4):S1–S14. 62. Eskander A, Kang SY, Teknos TN, et al. Advances in midface reconstruction: beyond the reconstructive ladder. Curr Opin Otolaryngol Head Neck Surg 2017; 25(5):422–430. 63. Swendseid BP, Roden DF, Vimawala S, et al. Virtual surgical planning in subscapular system free flap reconstruction of midface defects. Oral Oncol 2020;101:104508. 64. Dziegielewski PT, Bernard S, Mendenhall WM, et al. Osteoradionecrosis in osseous free flap reconstruction: Risk factors and treatment. Head Neck 2020; 42(8):1928–1938. 65. Million RR, Cassisi NJ. General principles for treatment of cancers in the head and neck: selection of treatment for the primary site and for the neck. In: Mil lion RR, Cassisi NJ, eds. Management of Head and Neck Cancer: A Multidisci plinary Approach . 1st ed. Philadelphia: J. B. Lippincott Company; 1984:43–62. 66. Overholt SM, Eicher SA, Wolf P, et al. Prognostic factors affecting outcome in lower gingival carcinoma. Laryngoscope 1996;106(11):1335–1339. 67. Byers RM, Anderson B, Schwarz EA, et al. Treatment of squamous carcinoma of the retromolar trigone. Am J Clin Oncol 1984;7(6):647–652. 68. Shibuya H, Horiuchi J, Suzuki S, et al. Oral carcinoma of the upper jaw. Results of radiation treatment. Acta Radiol Oncol 1984;23(5):331–335. 69. Huang CJ, Chao KS, Tsai J, et al. Cancer of retromolar trigone: long-term radiation therapy outcome. Head Neck 2001;23(9):758–763. 70. Cerezo L, Millan I, Torre A, et al. Prognostic factors for survival and tumor control in cervical lymph node metastases from head and neck cancer. A mul tivariate study of 492 cases. Cancer 1992;69(5):1224–1234. 71. Bartlett C, Taylor SM, Trites J, et al. Do we measure up? Is an objective mea suring device necessary for the accurate assessment of oral cavity and oropha ryngeal lesions? J Otolaryngol Head Neck Surg 2009;38(2):197–207. 72. Lowe VJ, Duan F, Subramaniam RM, et al. Multicenter trial of [(18)F]fluoro deoxyglucose positron emission tomography/computed tomography staging of head and neck cancer and negative predictive value and surgical impact in the n0 neck: results from ACRIN 6685. J Clin Oncol 2019;37(20):1704–1712. 73. Kyzas PA, Evangelou E, Denaxa-Kyza D, et al. 18F-fluorodeoxyglucose posi tron emission tomography to evaluate cervical node metastases in patients with head and neck squamous cell carcinoma: a meta-analysis. J Natl Cancer Inst 2008;100(10):712–720. 74. Stuckensen T, Kovacs AF, Adams S, et al. Staging of the neck in patients with oral cavity squamous cell carcinomas: a prospective comparison of PET, ultra sound, CT and MRI. J Craniomaxillofac Surg 2000;28(6):319–324. 75. Shim SJ, Cha J, Koom WS, et al. Clinical outcomes for T1-2N0-1 oral tongue cancer patients underwent surgery with and without postoperative radiotherapy. Radiat Oncol 2010;5:43. 76. Huang SH, Hwang D, Lockwood G, et al. Predictive value of tumor thickness for cervical lymph-node involvement in squamous cell carcinoma of the oral cavity: a meta-analysis of reported studies. Cancer 2009;115(7):1489–1497. 77. Dzioba A, Aalto D, Papadopoulos-Nydam G, et al. Correction to: functional and quality of life outcomes after partial glossectomy: a multi-institutional lon gitudinal study of the head and neck research network. J Otolaryngol Head Neck Surg 2017;46(1):59. 78. Balasubramanian D, Ebrahimi A, Gupta R, et al. Tumour thickness as a pre dictor of nodal metastases in oral cancer: comparison between tongue and floor of mouth subsites. Oral Oncol 2014;50(12):1165–1168. 79. Spiro RH, Huvos AG, Wong GY, et al. Predictive value of tumor thickness in squamous carcinoma confined to the tongue and floor of the mouth. Am J Surg 1986;152(4):345–350. 80. Spiro RH, Spiro JD, Strong EW. Surgical approach to squamous carcinoma confined to the tongue and the floor of the mouth. Head Neck Surg 1986;9(1): 27–31. 81. Fakih AR, Rao RS, Borges AM, et al. Elective versus therapeutic neck dissec tion in early carcinoma of the oral tongue. Am J Surg 1989;158(4):309–313. 82. D’Cruz AK, Vaish R, Kapre N, et al. Elective versus therapeutic neck dissec tion in node-negative oral cancer. N Engl J Med 2015;373(6):521–529. 83. Newman M, Dziegielewski PT, Nguyen NTA, et al. Relationship of depth of invasion to survival outcomes and patterns of recurrence for T3 oral tongue squamous cell carcinoma. Oral Oncol 2021;116:105195. 84. Lea J, Bachar G, Sawka AM, et al. Metastases to level IIb in squamous cell carcinoma of the oral cavity: a systematic review and meta-analysis. Head Neck 2010;32(2):184–190. 85. Agarwal SK, Arora SK, Kumar G, et al. Isolated perifacial lymph node metastasis in oral squamous cell carcinoma with clinically node-negative neck. Laryngo scope 2016;126(10):2252–2256. 86. Dziegielewski PT, McNeely ML, Ashworth N, et al. 2b or not 2b? Shoulder function after level 2b neck dissection: a double-blind randomized controlled clinical trial. Cancer 2020;126(7):1492–1501. 87. Dogan E, Cetinayak HO, Sarioglu S, et al. Patterns of cervical lymph node metastases in oral tongue squamous cell carcinoma: implications for elective and therapeutic neck dissection. J Laryngol Otol 2014;128(3):268–273. 88. Dias FL, Lima RA, Kligerman J, et al. Relevance of skip metastases for squa mous cell carcinoma of the oral tongue and the floor of the mouth. Otolaryngol Head Neck Surg 2006;134(3):460–465. 89. Kowalski LP, Bagietto R, Lara JR, et al. Factors influencing contralateral lymph node metastasis from oral carcinoma. Head Neck 1999;21(2):104–110.